Berger, T., & Meuer, S. (2014). Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics. Journal of neuroimmunology, 277(1/2), . https://doi.org/10.1016/j.jneuroim.2014.10.001
Chicago-Zitierstil (17. Ausg.)Berger, Thomas, und Stefan Meuer. "Predicting Therapeutic Efficacy of Intravenous Immunoglobulin (IVIG) in Individual Patients with Relapsing Remitting Multiple Sclerosis (RRMS) by Functional Genomics." Journal of Neuroimmunology 277, no. 1/2 (2014). https://doi.org/10.1016/j.jneuroim.2014.10.001.
MLA-Zitierstil (9. Ausg.)Berger, Thomas, und Stefan Meuer. "Predicting Therapeutic Efficacy of Intravenous Immunoglobulin (IVIG) in Individual Patients with Relapsing Remitting Multiple Sclerosis (RRMS) by Functional Genomics." Journal of Neuroimmunology, vol. 277, no. 1/2, 2014, https://doi.org/10.1016/j.jneuroim.2014.10.001.